Volver al buscador
FDAFDA · Alimentos y medicamentos·N.º oficial Z-1745-2026

MiniMed 720G Insulin Pump (MMT-1809, MMT-1810, MMT-1859, MMT-1860, MMT-1867)

Publicado el 8 de abril de 2026 · Inicio del retiro: 13 de febrero de 2026

Resumen

FDA registra el retiro Z-1745-2026 de dispositivos médicos de Clase II, publicado el 8 de abril de 2026 e iniciado el 13 de febrero de 2026. Empresa responsable: Medtronic MiniMed, Inc.; Estado: En curso; Cantidad reportada: 37,458; Lote: Pump: UDI-DI(GTIN): User Guide Name(Part-Version): MiniMed 720G Insulin Pump: 763000854768, 763000505196, 763000505219, 763000505318, 763000505257, 763000505295, 763000505233, 763000505370, 763000505325, 763000505332, 763000505394, 763000505356, 763000505387, 763000505349, 763000505400, 763000505226, 763000505271, 763000638016, 763000531171, 763000854751: MINIMED 720G SYSTEM USER GUIDE(M000187C022 1, M000186C002 1, M000186C014 1, M000187C016 1, M000186C021 1, M000186C018 1, M000186C017 1, M000187C010 1, M000187C011 1, M000186C031 1, M000187C013 1, M000187C008 1, M000187C015 1, M000187C005 1, M000187C033 1, M000186C028 1, M000187C023 1, M000187C020 1, M000187C018 1, M000186C018 13, M000186C004 1, M000186C030 1, M000186C009 1, M000187C024 1, M000186C033 1, M000186C003 1, M000187C012 1). La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.

Estado reportado al momento de publicación: Ongoing — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.

Qué peligro representa

All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death.

Qué hacer

Voluntary: Firm initiated · Letter

Recibe un correo cuando FDA publique un retiro como este

Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.

Detalles del retiro

Fabricante
Medtronic MiniMed, Inc.
Distribuidor
Worldwide - US Nationwide distribution including in the states of OR, CA, AZ, NY,TX,FL, OH, MO, TN,NJ, NC, SC, IL, VA, WA, DC, GA, PA, MS,IA, MI, NH, OK, SD, MT, WI, WV, MA, LA, MN, RI, AR, ME, AL, IN, UT, KY, CO, ND, MD, CT, NM, KS, ID, NV, DE, NE, VT, AK, HI, WY, PR, VI and the countries of Taiwan, New Zealand, Australia, Bangladesh, Brunei Darussalam, Cambodia, Indonesia, Malaysia, Maldives, Philippines, Thailand, Vietnam, Singapore, Pakistan, Hong Kong, China, Argentina, Aruba, Barbados, Bermuda, Bolivia, Plurinational State Of, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, El Salvador, Guatemala, Honduras, Mexico, Panama, Paraguay, Peru, Puerto Rico, Trinidad And Tobago, Uruguay, Venezuela, Canada, South Korea, India, Albania, Algeria, Andorra, Armenia, Austria, Azerbaijan, Bahrain, Belarus, Belgium, Bosnia And Herzegovina, Botswana, Bulgaria, Canary Islands, Croatia, Cyprus, Czech Republic, Denmark, Egypt, Estonia, Faroe Islands, Finland, France, French Guyana, French Polynes., Georgia, Germany, Gibraltar, Greece, Guadeloupe, Hungary, Iceland, Iran, Iraq, Ireland, Israel, Italy, Jordan, Kazakhstan, Kenya, Kosovo, Kuwait, Kyrgyzstan, Latvia, Lebanon, Libya, Liechtenstein, Lithuania, Luxembourg, Macedonia, Malawi, Malta, Martinique, Mauritius, Mayotte, Moldavia, Montenegro, Morocco, Namibia, Netherlands, New Caledonia, Nigeria, Northern Ireland, Norway, Oman, Poland, Portugal, Qatar, Reunion, Romania, Russia, San Marino, Saudi Arabia, Serbia, Sierra Leone, Slovakia, Slovenia, South Africa, Spain, St.Pier,Miquel., Sudan, Sweden, Switzerland, Syrian Arab Republic, Tanzania, Tunisia, Turkey, Turkmenistan, Ukraine, United Arab Emirates, United Kingdom, Uzbekistan, Yemen, Zambia, Zimbabwe.
Lote
Pump: UDI-DI(GTIN): User Guide Name(Part-Version): MiniMed 720G Insulin Pump: 763000854768, 763000505196, 763000505219, 763000505318, 763000505257, 763000505295, 763000505233, 763000505370, 763000505325, 763000505332, 763000505394, 763000505356, 763000505387, 763000505349, 763000505400, 763000505226, 763000505271, 763000638016, 763000531171, 763000854751: MINIMED 720G SYSTEM USER GUIDE(M000187C022 1, M000186C002 1, M000186C014 1, M000187C016 1, M000186C021 1, M000186C018 1, M000186C017 1, M000187C010 1, M000187C011 1, M000186C031 1, M000187C013 1, M000187C008 1, M000187C015 1, M000187C005 1, M000187C033 1, M000186C028 1, M000187C023 1, M000187C020 1, M000187C018 1, M000186C018 13, M000186C004 1, M000186C030 1, M000186C009 1, M000187C024 1, M000186C033 1, M000186C003 1, M000187C012 1).
Clasificación de riesgo
Class II
Área (FDA)
device
País
United States

Retiros relacionados

Preguntas sobre este retiro

¿MiniMed 720G Insulin Pump (MMT-1809, MMT-1810, MMT-1859, MMT-1860, MMT-1867) fue retirado del mercado?

Sí. FDA publicó el retiro Z-1745-2026 el 8 de abril de 2026. Peligro reportado: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death.

¿Qué debo hacer si tengo este producto?

Voluntary: Firm initiated · Letter